NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Paysafe Limited (“Paysafe” or the “Company”) (NYSE: PSFE) for violations of the federal securities laws on behalf of investors who purchased or acquired Paysafe securities between March 4, 2025 and November 12, 2025, inclusive (the “Class Period”). On October 16, 2025, a complaint was filed against the Company and ce ...

Core Viewpoint - A class action lawsuit has been filed against StubHub Holdings, Inc. for alleged violations of federal securities laws related to its September 2025 IPO, claiming that the Registration Statement was materially false and misleading [1][2]. Group 1: Lawsuit Details - The lawsuit is on behalf of all individuals and entities that purchased StubHub common stock in connection with the IPO [1]. - The complaint alleges that the Registration Statement omitted critical information regarding changes in payment timing to vendors, which adversely affected free cash flow [2]. - It is claimed that these omissions rendered the company's free cash flow reports materially misleading, impacting the credibility of positive statements made by the company regarding its business and prospects [2]. Group 2: Impact on Investors - Following the allegations, StubHub's common stock experienced a significant decline, resulting in financial losses for investors [3]. - Investors who suffered losses exceeding $100,000 in connection with the IPO are encouraged to participate in the lawsuit [3]. Group 3: Law Firm Background - Lowey Dannenberg P.C. is a law firm specializing in representing investors who have suffered financial losses due to corporate fraud and violations of federal securities laws [4]. - The firm has a history of prosecuting multi-million-dollar lawsuits and has recovered billions for its clients [4].

Core Viewpoint - A class action lawsuit has been filed against Perrigo Company plc for violations of federal securities laws, alleging misleading statements and undisclosed issues related to its infant formula business [1][2]. Summary by Sections Lawsuit Details - The lawsuit is on behalf of investors who purchased Perrigo securities between February 27, 2023, and November 4, 2025 [1]. - The complaint alleges that Perrigo and certain officers made false statements and failed to disclose significant operational issues in the infant formula business acquired from Nestlé [2]. Allegations Against Perrigo - Key allegations include: 1. Significant underinvestment in maintenance and operational improvements in the infant formula business [2]. 2. The need for substantial capital and operational expenditures beyond stated cost estimates to remediate the business [2]. 3. Manufacturing deficiencies in the infant formula facility [2]. 4. Overstated financial results, including earnings and cash flow, due to the aforementioned issues [2]. 5. Misleading positive statements regarding the Company's business and prospects [2]. Impact on Investors - Following the revelation of these issues, Perrigo's stock experienced a significant decline, resulting in financial losses for investors [3]. - Investors who suffered losses exceeding $150,000 are encouraged to participate in the lawsuit [3].

Core Viewpoint - Lowey Dannenberg P.C. is investigating Ramaco Resources Inc. for potential violations of federal securities laws following allegations of data manipulation related to its Brook Mine project [1][2]. Group 1: Allegations and Investigations - Wolfpack Research released a report on October 23, 2025, claiming that Ramaco's Brook Mine was a "hoax" and that the company manipulated data to misrepresent the profitability of its rare earths project [2]. - Investors who suffered losses exceeding $50,000 in Ramaco securities are encouraged to participate in the investigation [2]. Group 2: About Lowey Dannenberg - Lowey Dannenberg is a national law firm that represents institutional and individual investors who have experienced financial losses due to corporate fraud and violations of federal securities and antitrust laws [3]. - The firm has a strong track record in prosecuting multi-million-dollar lawsuits and has recovered billions for investors in the past [3].

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) for violations of the federal securities laws on behalf of investors who purchased or acquired DexCom securities between July 26, 2024 and September 17, 2025, inclusive (the “Class Period”). On October 27, 2025, a complaint was filed against the Company and cert ...

Core Viewpoint - A class action lawsuit has been filed against Marex Group PLC for violations of federal securities laws, impacting investors who acquired Marex securities between May 16, 2024, and August 5, 2025 [1][2] Summary by Sections Lawsuit Details - The lawsuit alleges that Marex and certain officers made false or misleading statements and failed to disclose critical information during the Class Period [2] - Specific allegations include the sale of over-the-counter financial instruments to itself, inconsistencies in financial statements between subsidiaries and related parties, and the unreliability of Marex's financial statements [2] Impact on Investors - Following the revelation of the truth, Marex's common stock experienced a significant decline, resulting in financial losses for investors [3] - Investors who suffered losses exceeding $50,000 are encouraged to participate in the lawsuit, with a deadline to act as Lead Plaintiff set for December 8, 2025 [3] About the Law Firm - Lowey Dannenberg P.C. specializes in representing institutional and individual investors affected by corporate fraud and has a history of recovering billions for clients [4]

Core Viewpoint - A class action lawsuit has been filed against Nutex Health Inc. for violations of federal securities laws, impacting investors who acquired Nutex securities during the specified Class Period from August 8, 2024, to August 14, 2025 [1][2]. Group 1: Allegations Against Nutex - The lawsuit alleges that Nutex and its officers made false and misleading statements regarding the company's financial practices and internal controls [2]. - Specific claims include that Nutex engaged in fraudulent activities through HaloMD, leading to unsustainable revenue and improper accounting of stock-based compensation obligations [2]. - The company is accused of overstating its financial prospects and failing to disclose material weaknesses in its internal controls over financial reporting [2]. Group 2: Impact on Investors - Following the revelation of these allegations, Nutex's common stock experienced a significant decline, resulting in financial losses for investors [3]. - Investors who suffered losses exceeding $50,000 are encouraged to participate in the lawsuit, with a deadline to act as Lead Plaintiff set for October 21, 2025 [3]. Group 3: About the Law Firm - Lowey Dannenberg P.C. is a law firm specializing in representing institutional and individual investors who have suffered financial losses due to corporate fraud and violations of federal securities laws [4]. - The firm has a track record of prosecuting multi-million-dollar lawsuits and has recovered billions for its clients [4].

Core Viewpoint - A class action lawsuit has been filed against SelectQuote, Inc. for violations of federal securities laws, impacting investors who acquired securities during the specified Class Period [1][2]. Summary by Relevant Sections Allegations Against SelectQuote - The lawsuit alleges that SelectQuote misled investors by making false statements and failing to disclose critical information regarding its business practices related to Medicare beneficiaries [2]. - Specific allegations include directing beneficiaries to plans that compensated SelectQuote rather than providing unbiased comparisons, receiving illegal kickbacks, and non-compliance with laws and regulations [2]. Impact on Investors - Following the revelation of these allegations, SelectQuote's stock experienced a significant decline, resulting in financial losses for investors [3]. - Investors who suffered losses exceeding $50,000 are encouraged to participate in the lawsuit, with a deadline for Lead Plaintiff applications set for October 10, 2025 [3]. Law Firm Background - Lowey Dannenberg P.C. is a law firm specializing in representing investors who have suffered losses due to corporate fraud and violations of securities laws, with a history of recovering billions for clients [4].

Core Viewpoint - Lowey Dannenberg P.C. is investigating KBR, Inc. for potential violations of federal securities laws, indicating possible legal issues for the company [1]. Group 1: Investigation Details - The investigation targets KBR, Inc. due to potential violations of federal securities laws, which may affect the company's reputation and financial standing [1]. - Investors who have suffered losses exceeding $100,000 in KBR securities are encouraged to participate in the investigation [2]. Group 2: About Lowey Dannenberg - Lowey Dannenberg is a law firm specializing in representing institutional and individual investors who have experienced financial losses due to corporate fraud and violations of federal laws [3]. - The firm has a strong track record in prosecuting multi-million-dollar lawsuits and has successfully recovered billions for investors [3].

Core Viewpoint - A class action lawsuit has been filed against UroGen Pharma Ltd. for alleged violations of federal securities laws during the Class Period from July 27, 2023, to May 15, 2025 [1] Group 1: Allegations Against UroGen - The lawsuit claims that UroGen and its officers made false or misleading statements regarding the ENVISION clinical study, which was not designed to provide substantial evidence of effectiveness for UGN-102 due to the absence of a concurrent control arm [2] - It is alleged that UroGen failed to heed FDA warnings about the study design, leading to a substantial risk that the New Drug Application (NDA) for UGN-102 would not be approved [2] - The misleading statements made by UroGen regarding its business and prospects resulted in significant investor losses when the truth was revealed [2][3] Group 2: Investor Impact - Investors who suffered losses exceeding $50,000 in UroGen's securities are encouraged to participate in the lawsuit, with a deadline to act before July 28, 2025 [3] - The decline in UroGen's stock price following the revelation of the truth has caused significant financial injury to investors [3] Group 3: About the Law Firm - Lowey Dannenberg P.C. is a law firm specializing in representing institutional and individual investors who have suffered financial losses due to corporate fraud and violations of federal securities laws [4] - The firm has a strong track record in prosecuting multi-million-dollar lawsuits and has recovered billions for its clients [4]